← Browse by Condition
Medical Condition
mss
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT07001592 Phase 1
Recruiting
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
Enrollment
18 pts
Location
United States
Sponsor
Allegheny Singer Research Inst...
NCT05815303 Phase 2
Recruiting
XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer
Enrollment
92 pts
Location
China
Sponsor
Cancer Institute and Hospital,...